How Cryptococcus fungi adapt to heat and resist drugs
Evolution of heat tolerance and drug resistance in Cryptococcus
This study looks at how certain fungi, which can cause serious infections in people with weakened immune systems like those with HIV/AIDS, change and adapt to warmer temperatures and antifungal treatments, helping us understand how climate change might affect their ability to make people sick.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Georgia NIH-funded |
| Lab location | 1 site (Athens, United States) |
| Project ID | NIH-10949109 on NIH RePORTER |
What this research studies
This research investigates how the Cryptococcus genus of fungi evolves in response to environmental changes, particularly focusing on their ability to tolerate higher temperatures and resist antifungal drugs. By examining the genetic factors that contribute to these traits, the study aims to understand how climate change may influence the pathogenicity of these fungi, which are known to cause severe infections in immunocompromised individuals, particularly those with HIV/AIDS. The research employs advanced genetic techniques to analyze the growth of Cryptococcus species at varying temperatures, providing insights into their adaptation mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV/AIDS who are at risk of Cryptococcus infections.
Not a fit: Patients who do not have HIV/AIDS or are not at risk for opportunistic fungal infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved strategies for preventing and treating infections caused by Cryptococcus, particularly in vulnerable populations.
How similar studies have performed: Previous research has shown success in understanding microbial adaptation to environmental changes, suggesting that this approach may yield valuable insights.
Where this research is happening
Athens, United States
- University of Georgia — Athens, United States (Active)
Researchers
- Principal investigator: Billmyre, Robert Blake — University of Georgia
- Study coordinator: Billmyre, Robert Blake
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.